Oramed Pharmaceuticals ROE 2011-2019 | ORMP

Current and historical return on equity (ROE) values for Oramed Pharmaceuticals (ORMP) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Oramed Pharmaceuticals ROE for the three months ending May 31, 2019 was -56.15%.
Oramed Pharmaceuticals ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-05-31 $-0.02B $0.02B -56.07%
2019-02-28 $-0.02B $0.03B -58.82%
2018-11-30 $-0.01B $0.03B -57.73%
2018-08-31 $-0.01B $0.03B -57.14%
2018-05-31 $-0.01B $0.02B -65.82%
2018-02-28 $-0.01B $0.02B -53.66%
2017-11-30 $-0.01B $0.02B -53.01%
2017-08-31 $-0.01B $0.02B -52.38%
2017-05-31 $-0.01B $0.02B -57.14%
2017-02-28 $-0.01B $0.02B -50.98%
2016-11-30 $-0.01B $0.02B -42.11%
2016-08-31 $-0.01B $0.03B -38.94%
2016-05-31 $-0.01B $0.03B -28.57%
2016-02-29 $-0.01B $0.03B -31.37%
2015-11-30 $-0.01B $0.02B -35.16%
2015-08-31 $-0.01B $0.03B -34.78%
2015-05-31 $-0.01B $0.02B -36.36%
2015-02-28 $-0.01B $0.02B -35.96%
2014-11-30 $-0.01B $0.02B -31.11%
2014-08-31 $-0.01B $0.02B -32.88%
2014-05-31 $-0.01B $0.02B -33.33%
2014-02-28 $-0.00B $0.02B -38.10%
2013-11-30 $-0.00B $0.01B -66.67%
2013-05-31 $-0.00B $0.00B -80.00%
2013-02-28 $-0.00B $0.01B -80.00%
2012-11-30 $-0.00B $0.01B -114.29%
2012-08-31 $-0.00B $0.00B -109.09%
2012-05-31 $-0.00B $0.00B -109.09%
2012-02-29 $-0.00B $0.00B -88.89%
2011-11-30 $-0.00B $0.00B -114.29%
2011-08-31 $-0.00B $0.00B -300.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.047B $0.002B
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.241B 20.46
Abbott Laboratories (ABT) United States $147.984B 26.99
Stryker (SYK) United States $75.300B 25.32
Boston Scientific (BSX) United States $59.042B 27.87
Baxter (BAX) United States $41.993B 25.46
EssilorLuxottica Societe Anonyme (ESLOY) France $33.354B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.273B 18.36
Terumo (TRUMY) Japan $26.625B 33.23
Coloplast (CLPBY) Denmark $25.164B 40.17
Lonza Group Ag (LZAGY) Switzerland $24.986B 0.00
ResMed (RMD) United States $21.042B 38.82
Smith & Nephew SNATS (SNN) United Kingdom $19.003B 0.00
Sunny Optical Technology (SNPTF) China $17.725B 0.00
Insulet (PODD) United States $10.867B 517.00
Bio-Rad Laboratories (BIO) United States $10.783B 51.75
Canopy Growth (CGC) Canada $7.072B 0.00
Hill-Rom Holdings (HRC) United States $6.911B 20.38
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.619B 12.34
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.070B 41.01
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
ICU Medical (ICUI) United States $3.829B 24.96
NuVasive (NUVA) United States $3.711B 29.22
Neogen (NEOG) United States $3.426B 57.33
Aurora Cannabis (ACB) Canada $3.210B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.143B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.069B 0.00
Quidel (QDEL) United States $2.764B 26.23
National Vision Holdings (EYE) United States $2.251B 50.80
Agios Pharmaceuticals (AGIO) United States $2.248B 0.00
Cardiovascular Systems (CSII) United States $1.559B 0.00
InMode (INMD) Israel $1.492B 0.00
Aphria (APHA) $1.245B 0.00
VAREX IMAGING (VREX) United States $1.148B 23.00
AtriCure (ATRC) United States $1.134B 0.00
Phibro Animal Health (PAHC) United States $0.950B 17.79
NanoString Technologies (NSTG) United States $0.887B 0.00
Lantheus Holdings (LNTH) United States $0.790B 19.75
TG Therapeutics (TGTX) United States $0.780B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.743B 28.44
Omeros (OMER) United States $0.715B 0.00
LeMaitre Vascular (LMAT) United States $0.700B 39.33
PetIQ (PETQ) United States $0.672B 16.39
Quanterix (QTRX) United States $0.667B 0.00
HEXO (HEXO) $0.653B 0.00
Cerus (CERS) United States $0.606B 0.00
Surmodics (SRDX) United States $0.538B 56.14
OraSure Technologies (OSUR) United States $0.485B 29.11
Organigram Holdings (OGI) Canada $0.447B 0.00
MacroGenics (MGNX) United States $0.423B 0.00
Owens & Minor (OMI) United States $0.390B 14.42
Utah Medical Products (UTMD) United States $0.376B 27.27
Meridian Bioscience (VIVO) United States $0.375B 12.93
BioLife Solutions (BLFS) United States $0.337B 137.33
Zynex (ZYXI) United States $0.296B 33.52
Neptune Wellness Solutions (NEPT) Canada $0.280B 0.00
Bovie Medical (APYX) United States $0.245B 0.00
Viemed Healthcare (VMD) United States $0.230B 0.00
United Health Products (UEEC) United States $0.221B 0.00
Vapotherm (VAPO) United States $0.220B 0.00
Repro-Med Systems (KRMD) United States $0.159B 0.00
InfuSystems Holdings (INFU) United States $0.154B 774.00
Liberty Health Sciences (LHSIF) Canada $0.153B 0.00
Rockwell Medical (RMTI) United States $0.136B 0.00
Cytosorbents (CTSO) United States $0.135B 0.00
Female Health (VERU) United States $0.131B 0.00
Fonar (FONR) United States $0.130B 9.18
Chimerix (CMRX) United States $0.124B 0.00
United-Guardian (UG) United States $0.089B 22.58
Chembio Diagnostics (CEMI) United States $0.071B 0.00
Nephros (NEPH) United States $0.065B 0.00
Surface Oncology (SURF) United States $0.059B 0.00
MTech Acquisition (KERN) United States $0.059B 0.00
MRI Interventions (MRIC) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.017B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00